
Molecular Diagnostics World Congress, 12-13 September 2013, San Diego, CA, USA
This area of research captures the expression patterns from both the genome and proteins and uses them to differentiate between what is normal and abnormal. There is lots of excitement in this field regarding the creation and development of new tools for improving the detection, diagnosis and treatment of cancer at the molecular level.
There will be particular focus on point-of-care diagnostics, predictive biomarkers and their discovery and detection. Additionally, the cutting-edge subjects of circulating tumour cells and diagnostic applications of exosomes will be explored, giving delegates a brilliant insight into this rapidly expanding field.
Keynote Speakers
Lita Nelsen, Director, Massachusetts Institute of Technology
Norman Nelson, Senior Consultant, NCN Enterprises
John Quackenbush, Professor of Computational Biology, Dana Farber Cancer Institute
Agenda Topics
• Cancer Personalised Medicine
• Companion Diagnostics
• Emerging Classes of Biomarkers for MDx
• Emerging technologies in MDx
• MDx for Infectious Diseases
• Next-Generation Sequencing: Its Impact on MDx
• Oncology Biomarkers
Registration
2for1 Offer!
Now, when you buy one full priced delegate pass, you can share the experience with a colleague for FREE!
This promotion expires on 31st December 2012, so be sure to register as soon as possible to take advantage!
Terms and Conditions apply. Visit
website for more information, and to
register.
Venue
Town and Country Resort Hotel
500 Hotel Circle North
San Diego
California
92108
Tel: 619-291-7131
More information on accommodation rates is on the
website.
Sponsorship and Exhibition Opportunities
Other enquiries
Hannah Tweed
+44 (0) 1787 315110